Drug Pricing Program Reporting Requirements

ICR 199708-0915-002

OMB: 0915-0176

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
IC ID
Document
Title
Status
6402
Migrated
ICR Details
0915-0176 199708-0915-002
Historical Active 199406-0915-001
HHS/HSA
Drug Pricing Program Reporting Requirements
Revision of a currently approved collection   No
Regular
Approved without change 09/30/1997
Retrieve Notice of Action (NOA) 08/06/1997
  Inventory as of this Action Requested Previously Approved
10/31/2000 10/31/2000 09/30/1997
21 0 70
94 0 740
0 0 0

The Office of Drug Pricing has developed, pursuant to section 340B of the PHS Act, audit guidelines and a dispute resolution process for the Drug Pricing Program. The asociated reporting requirements are necessary to provide participating entities with protection from abusive audits and to provide the information necessary to give entities and manufacturers fair "notice and hearing" opportunities.

None
None


No

1
IC Title Form No. Form Name
Drug Pricing Program Reporting Requirements

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 21 70 0 0 -49 0
Annual Time Burden (Hours) 94 740 0 0 -646 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
08/06/1997


© 2024 OMB.report | Privacy Policy